Related Experiment Video
Updated: Jul 6, 2025
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
17.9K
Angiotensin II and post-streptococcal glomerulonephritis.
Jesus A Mosquera-Sulbaran1, Adriana Pedreañez2, Yenddy Carrero3
1Facultad de Medicina, Instituto de Investigaciones Clínicas "Dr. Américo Negrette", Universidad del Zulia, Apartado Postal: 23, MaracaiboZulia, 4001-A, Venezuela. mosquera99ve@yahoo.com.
Clinical and Experimental Nephrology
|January 3, 2024
Summary
Post-streptococcal glomerulonephritis (PSGN) involves immune responses to streptococcus. This review explores how Angiotensin II (Ang II) may contribute to inflammation and kidney damage in PSGN.
Area of Science:
- Nephrology
- Immunology
- Microbiology
Background:
- Post-streptococcal glomerulonephritis (PSGN) arises from group A beta-hemolytic streptococcus infections.
- Immune responses, including antibody and immune complex formation, are triggered by streptococcal antigens.
- Renal immunological events can lead to kidney damage, potentially causing chronic renal failure.
Purpose of the Study:
- To investigate the potential role of Angiotensin II (Ang II) in the inflammatory processes of PSGN.
- To identify and define specific events linking Ang II to PSGN pathogenesis.
Main Methods:
- Literature review of immunological events during PSGN.
- Analysis of the known functions of Angiotensin II in inflammatory processes.
- Correlation of Ang II's properties with reported PSGN mechanisms.
Main Results:
- Angiotensin II possesses vasopressor and pro-inflammatory properties.
- Certain immunological events during PSGN suggest a role for Ang II.
- The review focuses on defining these reported events related to Ang II in PSGN.
Conclusions:
- Angiotensin II is a plausible factor in the inflammatory cascade of PSGN.
- Further research is warranted to elucidate the precise mechanisms of Ang II involvement in PSGN.
Related Concept Videos
01:25Antihypertensive Drugs: Direct Renin Inhibitors
632
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
632
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
645
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
645
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
735
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
735
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
433
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433
01:33Hormonal Regulation
33.2K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.2K
01:28Glomerular Filtration Rate and its Regulation
2.7K
The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
2.7K